about
Signal integration and gene induction by a functionally distinct STAT3 phosphoform.Ecto-5'-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells.Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response.Macrophage Migration Inhibitory Factor Secretion Is Induced by Ionizing Radiation and Oxidative Stress in Cancer Cells.Stereotactic Radiosurgery for Renal Cancer Brain Metastasis: Prognostic Factors and the Role of Whole-Brain Radiation and Surgical Resection.Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL statusMetastases of renal cell carcinoma to the thyroid gland with synchronous benign and malignant follicular cell-derived neoplasms.Metastatic clear cell renal carcinoma - an unusual response to Temsirolimus in second line therapy.Renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy.DLK1: a novel target for immunotherapeutic remodeling of the tumor blood vasculature.Obstructive jaundice due to ampullary metastasis of renal cell carcinomaInfiltrating macrophages increase RCC epithelial mesenchymal transition (EMT) and stem cell-like populations via AKT and mTOR signaling.Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling.Renal cell carcinoma alters endothelial receptor expression responsible for leukocyte adhesion.Effects of the novel heat shock protein 90 inhibitor AUY922 in renal cell carcinoma ACHN and 786-O cells.Emerging growth factor receptor antagonists for the treatment of renal cell carcinoma.Resistance to the mTOR inhibitor temsirolimus alters adhesion and migration behavior of renal cell carcinoma cells through an integrin α5- and integrin β3-dependent mechanism.Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas.HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism.Translation in solid cancer: are size-based response criteria an anachronism?Association of high cost sharing and targeted therapy initiation among elderly Medicare patients with metastatic renal cell carcinoma.DNA-methylation-mediated repression of miR-766-3p promotes cell proliferation via targeting SF2 expression in renal cell carcinoma.LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.Targeted Therapy for Metastatic Renal Carcinoma: an Update.
P2860
Q33602531-E74AAB3B-735A-488A-84EA-34A275A57882Q33761985-41A927CE-02B3-42EA-AEDF-9B6CF25E3E5CQ34278609-368ECBF2-1313-4C83-AB85-DE3C03F13FA5Q35888073-952B324C-B0D1-49D6-A41E-F7DBB3E9C4E5Q36343152-CE1FBA12-F957-4A0E-9602-19A097386DDBQ36544528-23EA848B-0E0A-4F42-9081-97D1B88B1A01Q36804964-BDAA2543-E230-411E-8BFC-1E954A5A2A73Q36890998-DB01CE51-3398-4712-817A-6B49C3446742Q37153397-424AB503-31DA-426E-9207-F7281C6835E5Q37254877-A544F088-1126-4386-A4F4-68C9286B9047Q37372287-8CFD6D6C-8457-4619-A46E-A49A82ED5B46Q37536932-67C305BB-AAC0-4D0C-A26C-47BFFD37E7DDQ37650629-8D61F604-64E9-452A-AE21-81531A5710BFQ38788951-FB249E94-EBA5-4E3C-A7BC-186411B1AB83Q38815491-7E5C3E49-8BDC-493D-BDB4-6A70D10684B6Q38815893-7A4AC467-5F99-479E-BD1E-4EC9422BE46DQ38991418-5F5E227A-03F9-47D0-AFEE-F48413137328Q39041639-41C1B928-E0FC-4A3B-B5B0-031FDABB807DQ41134647-D0900992-C019-4BB5-B712-E4CC74F4B938Q47096217-06B60093-3AD5-458C-A1AE-395244A99A59Q47445819-E73DACD1-947F-4A71-ACA8-5F6CCB0C6B90Q48195326-30A46EED-0C5B-427A-944A-C4256DD371C4Q48212199-FD4D766D-E3B4-4F9F-A5F0-439AC6EEE406Q50927478-E63B8193-7AFF-4ED3-8F3C-44D0FDF7CB78Q51763279-95315E81-9668-43CA-A531-257BE2671BDB
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Novel agents in renal carcinoma: a reality check.
@ast
Novel agents in renal carcinoma: a reality check.
@en
type
label
Novel agents in renal carcinoma: a reality check.
@ast
Novel agents in renal carcinoma: a reality check.
@en
prefLabel
Novel agents in renal carcinoma: a reality check.
@ast
Novel agents in renal carcinoma: a reality check.
@en
P2860
P356
P1476
Novel agents in renal carcinoma: a reality check.
@en
P2093
Brian I Rini
Yana G Najjar
P2860
P304
P356
10.1177/1758834012443725
P577
2012-07-01T00:00:00Z